Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

3,256 evidence items · page 68 / 131

66.4 %Plasmodium falciparum parasites were detected in 66.4% (206/310) of blood samples from febrile patients in Gabon by 18S rRNA QT-NASBA.

Gabonpaludismepublished 2017The American journal of tropical medicine and hygieneeurope_pmcdocument of 4 observations

45 %Plasmodium falciparum accounted for 45% of neonatal malaria cases.

Gabonpaludismepublished 2025BMC infectious diseasesPubMeddocument of 17 observations

98 %In part A, the PCR-corrected adequate clinical and parasitological response at day 29 was 98% (95% CI 88–100) for the 3-day regimen of ganaplacide 400 mg plus lumefantrine-SDF 960 mg.

Gabonpaludismepublished 2023The Lancet. Infectious diseasesPubMeddocument of 10 observations

69.84 %Among 70 malaria-positive patient samples screened for polymorphism in Libreville, Gabon, the quadruple IRNI-SGKAA mutation in Pfdhfr-Pfdhps combination occurred in 69.84% of samples.

Gabonpaludismepublished 2023Malaria journalPubMeddocument of 11 observations

23.1 %The wild-type pfmdr1 N86 increased from 23.1% in 2009 to 100% in 2024 in Lambaréné, Gabon.

Gabonpaludismeobserved 2009published 2026International journal of molecular scienceseurope_pmcdocument of 6 observations

80 %The incidence of death in children requiring mechanical ventilation was 80%.

Gabondiarrhéeobserved August 2009 to July 2013published 2017Clinical Pediatrics Open AccessOpenAlexdocument of 3 observations

Gabon experienced simultaneous outbreaks of chikungunya and Dengue serotype 2 (DENV-2) viruses in 2007 and again in 2010.

Gabonchikungunya · Dengue serotype 2 (DENV-2)observed 2007, 2010published 2013PLoS ONEOpenAlexdocument of 2 observationsDOI 10.1371/journal.pone.0078030

47.7 per_100000Pour la période 2013-2017, l’incidence globale du cancer dans le Grand Libreville était de 47,7 pour 100 000 habitants chez les hommes.

Gaboncancer (non précisé)observed 2013-2017HAL · Unilimdocument of 322 observations

50 allelesA total of 50 individual alleles were identified (23 for msp1 and 27 for msp2) in Plasmodium falciparum/Plasmodium malariae isolates.

Gabonpaludismepublished 2022Parasitology internationaleurope_pmcdocument of 7 observationsDOI 10.1016/j.parint.2022.102590

1.071 odds-ratioLa prévalence de l'infection à Plasmodium falciparum est associée à l'âge avec un odds-ratio de 1,071 (intervalle de confiance à 95 % : 1,012–1,13 ; p = 0,017).

GabonpaludismeHAL · Unilimdocument of 36 observations

24.6 %One-quarter (24.6%) of study children experienced full therapeutic failure with immunological and virological nonresponses.

GabonVIH/sidapublished 2020Journal of clinical medicine researchPubMeddocument of 4 observations

33.3 per_100Nearly 1 in 3 subjects with sickle cell disease had no medical follow-up and no treatment in Gabon.

GabondrépanocytoseHAL · Unilimdocument of 71 observations

61 %La prévalence de Plasmodium spp. était de 61,0 % chez les enfants âgés de 10 à 12 ans.

GabonpaludismeHAL · Unilimdocument of 81 observations

4.8 %Altered consciousness was observed in 4.8% of severe malaria cases.

Gabonpaludismeobserved 2019published 2023BMC Infectious DiseasesOpenAlexdocument of 14 observationsDOI 10.1186/s12879-023-08133-y

56.7 %56.7% of all Staphylococcus aureus isolates (n = 261) carried Panton-Valentine leukocidin encoding genes.

GabonPanton-Valentine leukocidin · Staphylococcus aureuspublished 2014Clinical microbiology and infection : the official publication of the European Society of europe_pmcdocument of 5 observationsDOI 10.1111/1469-0691.12417

89.8 %Digestive colonisation with Candida spp. was detected in 97 out of 108 people living with HIV in Libreville, representing a rate of 89.8%.

Gabondigestive candidiasispublished 2026Microorganismseurope_pmcdocument of 4 observations

42 %In Lambaréné, Gabon, the HIV coinfection rate among adult TB patients was 42% between 2012 and 2014.

Gabontuberculose · VIH/sidaobserved 2012 and 2014published 2016The American journal of tropical medicine and hygieneeurope_pmcdocument of 12 observationsDOI 10.4269/ajtmh.15-0668

97.6 %At day 28, the PCR-adjusted efficacy of dihydroartemisinin-piperaquine was 97.6%.

Gabonpaludismepublished 2011PLoS medicineeurope_pmcdocument of 15 observations

96 %In part B, the PCR-corrected adequate clinical and parasitological response at day 29 was 96% (95% CI 77–100) for the artemether plus lumefantrine control regimen in children.

Gabonpaludismepublished 2023The Lancet. Infectious diseasesPubMeddocument of 10 observations

5 %5% of patients were over 5 years of age.

Gabondiabète de type 1published 2019International journal of pediatrics & adolescent medicinePubMeddocument of 7 observations

3 cases_per_person_yearThe highest-transmission-intensity group had a malaria incidence of 3 cases per person-year.

Gabonpaludismepublished 2022The Journal of infectious diseasesPubMeddocument of 5 observations

91 %After confirming the presence or absence of RVA gastroenteritis, the SD BIOLINE Rota/Adeno Ag rapid diagnostic test showed 91% concordance with RT-qPCR.

Gabonrotaviruspublished 2023Virology journaleurope_pmcdocument of 3 observations

Lower sensitivity was observed only in individuals who had cleared their HCV infection (presence of HCV-specific Ab in absence of HCV RNA).

Gabonhépatite Cpublished 2018Journal of virological methodsPubMeddocument of 5 observations

54 %More than half (54.0%) of 50 anal swabs from men who have sex with men in Bamako, Mali were infected by at least one HPV genotype targeted by the Gardasil-9® vaccine.

Gaboninfection à HPVpublished 2021Infectious agents and cancerPubMeddocument of 10 observations

7.6 %The prevalence of hepatitis B virus (HBV) surface antigen was 7.6% in rural populations.

Gabonhépatite Bpublished 2009Journal of Clinical MicrobiologyOpenAlexdocument of 2 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.